Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 3311097)

1.
2.

From hypertension to heart failure. Develop an exit strategy.

Lovett SJ.

Adv NPs PAs. 2011 May;2(5):33-4, 50. No abstract available.

PMID:
25693285
3.

Managing patients with cardiorenal syndrome: time to look to the gut?

Zachariah D, Kalra PR.

Eur J Heart Fail. 2012 Aug;14(8):870-2. doi: 10.1093/eurjhf/hfs098. Epub 2012 Jun 26. No abstract available.

PMID:
22736738
5.

[Not Available].

ROTHSCHUH KE.

Pflugers Arch Gesamte Physiol Menschen Tiere. 1947 Aug 15;249(4):339-53. Undetermined Language. No abstract available.

PMID:
20268864
6.

Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.

Rademaker MT, Charles CJ, Nicholls MG, Richards AM.

Circ Heart Fail. 2009 Nov;2(6):532-40. doi: 10.1161/CIRCHEARTFAILURE.109.861336. Epub 2009 Sep 22.

7.

THE DISTRIBUTION OF WATER AND ELECTROLYTES BETWEEN BLOOD AND SKELETAL MUSCLE IN EXPERIMENTAL HYPERTENSION.

Eichelberger L; Technical Assistance of Michael Roma.

J Exp Med. 1943 Mar 1;77(3):205-13.

8.

Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion.

Ali SS, Olinger CC, Sobotka PA, Dahle TG, Bunte MC, Blake D, Boyle AJ.

Congest Heart Fail. 2009 Jan-Feb;15(1):1-4. doi: 10.1111/j.1751-7133.2008.00037.x.

PMID:
19187399
9.

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.

Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P.

Am J Cardiol. 2009 Jan 1;103(1):93-102. doi: 10.1016/j.amjcard.2008.08.043. Epub 2008 Oct 17.

PMID:
19101237
10.

[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].

Alcázar Arroyo R.

Nefrologia. 2008;28 Suppl 3:87-93. Spanish.

PMID:
19018744
11.

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.

Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.

Biochem Pharmacol. 2008 Mar 15;75(6):1322-30. doi: 10.1016/j.bcp.2007.11.011. Epub 2007 Dec 3.

PMID:
18179782
12.

Relation of loop diuretic dose to mortality in advanced heart failure.

Eshaghian S, Horwich TB, Fonarow GC.

Am J Cardiol. 2006 Jun 15;97(12):1759-64. Epub 2006 Apr 27.

PMID:
16765130
13.

Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.

Dieterich HA, Wendt C, Saborowski F.

Fiziol Cheloveka. 2005 Nov-Dec;31(6):97-105. Review.

PMID:
16366159
14.

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.

PMID:
15309695
15.

Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure.

BIRKENFELD LW, LEIBMAN J, O'MEARA MP, EDELMAN IS.

J Clin Invest. 1958 May;37(5):687-98. No abstract available.

16.

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.

Am Heart J. 2003 Mar;145(3):459-66.

PMID:
12660669
18.

[Changes in calcium levels in blood and urine during various regimens of table salt intake in patients with essential arterial hypertension].

Tasić N, Nesović M, Djurić D, Kanjuh V.

Srp Arh Celok Lek. 2002 Jan-Feb;130(1-2):7-12. Serbian.

PMID:
12073292
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk